更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
辉瑞mRNA流感疫苗三期数据显示其效力比标准疫苗高出34.5%
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot securing 34.5% greater effectiveness compared to...
据《自然》杂志研究报道,Illumina全基因组测序揭示常见疾病背后更多遗传信号——PR Newswire发布
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study PR Newswire
现在为何说龙沙集团(LZAGY)是绝佳的“抄底”股票——纳斯达克解析
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now Nasdaq
以下原因说明朗盛集团(LZAGY)当前是绝佳的“抄底”良机——雅虎财经
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance
Illumina®蛋白质制备技术发布,推动蛋白质组学深入洞察以加速药物研发进程——PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
Lonza集团(LZAGY)作为强劲势头股,值得买入吗?——纳斯达克
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? Nasdaq
Cytiva在瑞士西部健康谷——大日内瓦伯尔尼地区的战略扩张
Cytiva’s strategic expansion in Western Switzerland’s Health Valley Greater Geneva Bern area
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页